HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Piscroside C inhibits TNF-α/NF-κB pathway by the suppression of PKCδ activity for TNF-RSC formation in human airway epithelial cells.

AbstractBACKGROUND:
Piscroside C, isolated from Pseudolysimachion rotundum var. subintegrum, is a novel iridoid glycoside with therapeutic efficacy in a mouse model of chronic obstructive pulmonary disease (COPD). Piscroside C has been reported as a constituent of YPL-001 (under Phase 2a study, ClinicalTrials.gov identifier NCT02272634).
PURPOSE:
To investigate the mechanisms behind piscroside C therapeutic effects on COPD in human airway epithelial NCI-H292 cells.
METHODS:
We tested if piscroside C effectively suppresses MUC5AC gene expression and TNF-RSC/IKK/NF-κB cascades in TNF-α-stimulated NCI-H292 cells by employing, reverse transcription-polymerase chain reaction, enzyme-linked immunosorbent assay, luciferase reporter assays, chromatin immunoprecipitation assays and immunoprecipitation.
RESULTS:
Piscroside C markedly suppressed the expression of TNF-α-induced MUC5AC mucus protein by inhibiting the transcriptional activity of NF-κB in NCI-H292 cells. Indeed, piscroside C negatively regulated the function of TNF receptor 1 signaling complex (TNF-RSC, an upstream regulator of the NF-κB pathway) without affecting its extracellular interaction with the TNF-α ligand. This inhibitory effect by piscroside C is mediated by the inactivation of protein kinase C (PKC), an essential regulator of TNF-RSC. PKC inactivation by piscroside C results in decreased PKCδ binding to a TRAF2 subunit of TNF-RSC and subsequent reduced IKK phosphorylation, resulting in NF-κB inactivation.
CONCLUSION:
We propose that piscroside C is a promising therapeutic constituent of YPL-001 through its inhibition of PKCδ activity in the TNF-RSC/IKK/NF-κB/MUC5AC signaling cascade.
AuthorsSu Ui Lee, Seoghyun Lee, Hyunju Ro, Ji-Hee Choi, Hyung Won Ryu, Mun-Ock Kim, Heung Joo Yuk, Jinhyuk Lee, Sung-Tae Hong, Sei-Ryang Oh
JournalPhytomedicine : international journal of phytotherapy and phytopharmacology (Phytomedicine) Vol. 40 Pg. 148-157 (Feb 01 2018) ISSN: 1618-095X [Electronic] Germany
PMID29496167 (Publication Type: Journal Article)
CopyrightCopyright © 2018 Elsevier GmbH. All rights reserved.
Chemical References
  • Iridoid Glycosides
  • MUC5AC protein, human
  • Mucin 5AC
  • Multiprotein Complexes
  • NF-kappa B
  • PSMD2 protein, human
  • Receptors, Tumor Necrosis Factor, Type I
  • TNF Receptor-Associated Factor 2
  • Tumor Necrosis Factor-alpha
  • piscroside C
  • Protein Kinase C-delta
Topics
  • Bronchi (cytology)
  • Cell Line
  • Epithelial Cells (drug effects)
  • Gene Expression (drug effects)
  • Humans
  • Iridoid Glycosides (pharmacology)
  • Mucin 5AC (genetics, metabolism)
  • Multiprotein Complexes
  • NF-kappa B (metabolism)
  • Phosphorylation (drug effects)
  • Protein Kinase C-delta (antagonists & inhibitors, metabolism)
  • Pulmonary Disease, Chronic Obstructive (drug therapy, pathology)
  • Receptors, Tumor Necrosis Factor, Type I (metabolism)
  • Signal Transduction (drug effects)
  • TNF Receptor-Associated Factor 2 (metabolism)
  • Tumor Necrosis Factor-alpha (metabolism, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: